Ensign Peak Advisors’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Sell |
183,308
-8,533
| -4% | -$667K | 0.02% | 388 |
|
|
2025
Q1 | $13.9M | Sell |
191,841
-19,895
| -9% | -$1.44M | 0.03% | 382 |
|
|
2024
Q4 | $15.7M | Sell |
211,736
-10,950
| -5% | -$811K | 0.03% | 362 |
|
|
2024
Q3 | $14.7M | Sell |
222,686
-17,200
| -7% | -$1.14M | 0.03% | 381 |
|
|
2024
Q2 | $22.2M | Sell |
239,886
-25,590
| -10% | -$2.36M | 0.04% | 301 |
|
|
2024
Q1 | $25.4M | Buy |
265,476
+3,949
| +2% | +$377K | 0.05% | 279 |
|
|
2023
Q4 | $19.9M | Buy |
261,527
+29,234
| +13% | +$2.23M | 0.04% | 299 |
|
|
2023
Q3 | $16.1M | Sell |
232,293
-9,171
| -4% | -$635K | 0.03% | 299 |
|
|
2023
Q2 | $22.8M | Buy |
241,464
+10,610
| +5% | +$1M | 0.05% | 275 |
|
|
2023
Q1 | $19.1M | Sell |
230,854
-93,366
| -29% | -$7.72M | 0.04% | 288 |
|
|
2022
Q4 | $24.2M | Buy |
324,220
+258,313
| +392% | +$19.3M | 0.05% | 266 |
|
|
2022
Q3 | $5.45M | Sell |
65,907
-3,485
| -5% | -$288K | 0.01% | 504 |
|
|
2022
Q2 | $6.6M | Sell |
69,392
-3,430
| -5% | -$326K | 0.02% | 464 |
|
|
2022
Q1 | $8.57M | Sell |
72,822
-110,205
| -60% | -$13M | 0.02% | 460 |
|
|
2021
Q4 | $23.7M | Buy |
183,027
+116,418
| +175% | +$15.1M | 0.05% | 291 |
|
|
2021
Q3 | $7.54M | Buy |
66,609
+114
| +0.2% | +$12.9K | 0.02% | 508 |
|
|
2021
Q2 | $6.89M | Sell |
66,495
-8,570
| -11% | -$888K | 0.01% | 534 |
|
|
2021
Q1 | $6.28M | Sell |
75,065
-23,315
| -24% | -$1.95M | 0.01% | 547 |
|
|
2020
Q4 | $8.98M | Sell |
98,380
-224,565
| -70% | -$20.5M | 0.02% | 440 |
|
|
2020
Q3 | $25.8M | Buy |
322,945
+82,730
| +34% | +$6.6M | 0.07% | 256 |
|
|
2020
Q2 | $16.6M | Buy |
240,215
+191,272
| +391% | +$13.2M | 0.05% | 325 |
|
|
2020
Q1 | $9.23M | Sell |
48,943
-27,410
| -36% | -$5.17M | 0.03% | 368 |
|
|
2019
Q4 | $17.8M | Buy |
+76,353
| New | +$17.8M | 0.05% | 307 |
|